Cnota; Peter Jurgen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cnota; Peter Jurgen.The latest application filed is for "novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases".

Company Profile

0.7.10

Cnota; Peter Jurgen - Bad Homburg N/A DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating underlying inflammation from COPD or asthma Grant 10,537,550 - Goede , et al. Ja	2020-01-21
Combination of anticholinergics, .beta.2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases Grant 8,518,918 - Maus , et al. August 27, 2	2013-08-27
Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases Grant 8,268,864 - Fyrnys , et al. September 18, 2	2012-09-18
Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases App 20120076739 - MAUS; Joachim ; et al.	2012-03-29
Combination of R,R-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases Grant 8,048,910 - Maus , et al. November 1, 2	2011-11-01
Combination of anticholineric and .beta. mimetics for the treatment of respiratory diseases Grant 7,985,766 - Goede , et al. July 26, 2	2011-07-26
Combination of Anticholinergics and Glucocorticoids for the Long-Term Treatment of Asthma and COPD App 20080300226 - Goede; Joachim ; et al.	2008-12-04
Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases App 20070270481 - Goede; Joachim ; et al.	2007-11-22
Novel combination of anticholinergics - B2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases App 20070196285 - Maus; Joachim ; et al.	2007-08-23
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases App 20060251589 - Maus; Joachim ; et al.	2006-11-09
Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases App 20060252815 - Goede; Joachim ; et al.	2006-11-09
Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases App 20060211729 - Fyrnys; Beatrix ; et al.	2006-09-21
Novel combination of anticholinergic and ss mimetics for the treatment of respiratory diseases App 20050175549 - Goede, Joachim ; et al.	2005-08-11
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases App 20050175547 - Maus, Joachim ; et al.	2005-08-11
Combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and COPD App 20050175548 - Goede, Joachim ; et al.	2005-08-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.